 |
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2014-05-14 00:00:00 |
| Sponsor | Karyopharm Therapeutics, Inc.;2 Mercer Road;Natick, Massachusetts, 01760 |
